This information was published on 2025-02-13T04:26:46 for IP Right Filed Published.
| Field | Value |
| (210) | 2521754 (IR 1838626) |
| (220) |
05 Nov 2024
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical drugs for inhibiting tumors; medicines for human purposes; drugs for medical purposes; pharmaceutical preparations; pharmaceutical tablets; nutritional supplements; dressings, medical; chemico-pharmaceutical preparations. |
| (540) | ANL |
| (550) | Word |
| (730) |
Hangzhou Adlai Nortye Biopharma Co., Ltd.
|
Find out more about publications on the About page.